An English procurement route depends on more than finding an online listing: you must establish the product’s UK status, the legally responsible importer and the supplier’s authority to distribute it. By the end, you will have a buying specification, verification checklist and quote format for comparing lawful supply options and landed costs.
Key takeaways
- Check MHRA marketing authorisation status before requesting Tazret stock.
- Specify tazarotene strength, gel format, pack size and required documentation.
- Compare product price, freight, duty, VAT and compliance costs in landed quotes.
- Ask importers for licences, batch documents and England delivery terms.
Start with the UK product-status check before requesting stock
Before you request stock, establish the product’s legal status in Great Britain. “Tazret Gel 0.05” is a brand description, not proof of a UK marketing authorisation, and an online listing can confuse international availability with lawful supply in England.
1. Search the MHRA Products database using the exact product name, tazarotene, strength and pharmaceutical form. Record whether the entry is current, the marketing-authorisation number, licence holder and authorised presentation. Specify tazarotene gel as 0.05% w/w, equal to 0.5 mg/g, so a supplier cannot quote a 0.1% product.
2. If no current UK authorisation matches, ask the supplier to state the proposed legal route in writing. The answer must identify whether it is a licensed special, an imported medicine requiring patient-specific supply, or another permitted route. Do not treat “available from India” as permission to import or routinely distribute it.
3. Verify the UK-side regulatory chain before placing an order. Obtain the importing company’s name, applicable MHRA manufacturer/import authorisation, Qualified Person arrangements for batch certification or release, and wholesale authorisation where a wholesaler is involved. Confirm who handles pharmacovigilance, complaints and recalls.
4. Keep the database result, supplier declarations, licences, purchase order, batch documents, delivery conditions and any temperature or transport-deviation record in the procurement file. That evidence is essential if your search began with “buy Tazret Gel 0 Point 05 in England” but the offered stock originated outside the UK.
Choose the correct procurement route: wholesaler, specials supplier or importer
The lawful route depends on the product’s UK status, not the Indian brand name. A UK-authorised Tazret product can enter routine pharmacy procurement through a wholesaler holding a Wholesale Dealer Authorisation (WDA(H)); an unlicensed product requires the specials route and a regulated buyer.
| Route | What the supplier must establish | When it applies |
|---|---|---|
| UK wholesaler | A valid UK marketing authorisation, exact product match, authorised wholesale activity and traceable batch supply | Routine supply of a product authorised for Great Britain |
| Specials supplier or importer | The appropriate MHRA licence, licensed manufacturing or import arrangements, batch documentation and a supply linked to the prescriber’s responsibility | An unlicensed medicine supplied for an individual patient’s clinical need |
| Overseas exporter alone | Export capability does not prove UK import, wholesale, batch-release or recall authority | Not a complete lawful route into England |
A pharmacy must obtain and dispense a special through the applicable prescription and procurement process; a prescriber must accept responsibility for the patient-specific use. Do not treat a website offering or the phrase “tazret gel 0 point 05 supplier in england” as proof of lawful stock.
Ask the proposed supplier to identify the UK importer, licence number and scope, batch-release arrangements, pharmacovigilance contact and recall owner. If the seller cannot name those parties, stop the purchase. A manufacturer’s licence in India alone does not authorise direct supply to an English pharmacy, prescriber or other regulated buyer.
Write a purchase specification that prevents the wrong gel from being quoted
State the product as tazarotene gel 0.05% w/w, equivalent to 0.5 mg/g. Specify the gel dosage form, not merely “tazarotene topical”: cream, lotion and gel are different presentations and must not be substituted.
Include these requirements in the request for quotation:
- Exact brand or generic status: Tazret Gel 0.05, or an expressly approved equivalent; do not accept 0.1% tazarotene.
- Net fill per tube, primary container, closure, label language and packaging artwork for approval.
- Units per shipper, minimum order quantity, storage conditions and minimum remaining shelf life on arrival.
- Batch number, manufacturing date and expiry date for every offered batch.
- Batch-specific certificate of analysis and release certificate, plus current stability information and GMP evidence.
- The UK marketing authorisation number, or a clear statement that the product is an imported medicine or licensed special.
- The name and licence details of the UK wholesaler, importer or other responsible entity handling the consignment.
- The legally supplied English product information, including contraindications and pregnancy warnings for this topical retinoid.
- Country of manufacture, proposed shipping origin and a sample pack or label images before acceptance.
A listing described as “tazarotene gel wholesale” does not prove UK-authorised status or lawful patient supply. Require the supplier to state the supply route and provide traceability from manufacturer to your receiving record, rather than quoting only a unit price.
Ask for a distributor quote that shows the real landed cost
A low unit price is meaningless if it excludes import handling, release work or non-compliant stock disposal. Ask for a tazret distributor quote that identifies the legal supply route and shows the complete landed cost to an England delivery address.
- State the product as tazarotene gel 0.05% w/w (0.5 mg/g), with pack size, units per carton, batch and expiry details, minimum order quantity, sample policy and available shelf life.
- Request the price basis, currency, quote-validity period, payment terms, lead time and Incoterm. Separate ex-works or India-origin pricing from the delivered price.
- Itemise freight, insurance, customs duty and VAT treatment, import handling, UK-authorised storage, testing, Qualified Person release, relabelling and destruction charges.
- Require the supplier’s legal name, registered address, MHRA licence or registration details, and confirmation that its premises hold a WDA(H) covering wholesale distribution of human medicines.
- Name the legally responsible UK importer for Indian-origin stock, the applicable manufacturer/import authorisation and the Qualified Person arrangement.
- Confirm GDP controls: temperature range, transport qualification, deviation handling, batch records, supplier qualification and recall responsibility.
- State whether the product is UK-authorised, a licensed special or an imported unlicensed medicine requiring patient-specific supply.
| Quote comparison | Acceptable detail | Warning sign |
|---|---|---|
| Price | Landed cost in England | “Ex-works only” |
| Route | UK-authorised stock or named importer | Vague “international supply” |
| Compliance | WDA(H), GDP records and traceability | UK trading address alone |
| Delivery | Written lead time and temperature-controlled transport | No batch or expiry commitment |
A quote that omits these fields cannot support a reliable procurement decision.
Compare an Indian exporter with an England-ready supply chain
An Indian exporter is not automatically an England-ready supplier. For a tazarotene gel pharmaceutical exporter, verify the UK party that imports, holds or supplies the medicine, and accepts legal responsibility for the consignment.
Check the exact product and current marketing-authorisation status in the MHRA Products database; an Indian brand name does not prove routine UK supply.
| Check | Indian exporter alone | England-ready supply chain |
|---|---|---|
| UK authorisation | Provides overseas product details | Identifies the UK marketing authorisation, or documents the lawful unlicensed-import route |
| Import and wholesale | Names no UK licence holder | Names the importer, Qualified Person arrangements and WDA(H) holder where wholesale distribution applies |
| GMP evidence | Sends a generic certificate | Provides current site-specific GMP evidence and batch release records |
| GDP controls | Quotes freight without controls | Shows storage, transport, temperature-excursion handling and delivery records |
| Recall responsibility | Says the buyer handles problems | Names the company managing complaints, pharmacovigilance, notifications and product recall |
Ask the proposed tazret gel 0 point 05 supplier in england for:
- MHRA licence or registration details for the company and premises
- Importer identity, WDA(H) number and QP release route
- Batch-specific certificate of analysis, release certificate, manufacturing and expiry dates
- Approved label artwork, stability information and transport conditions
- Written recall procedure naming the responsible UK contact
Retain these documents with the supplier qualification, purchase order, delivery record and any temperature deviation report. NIBA HEALTHCARE can be assessed against the same evidence rather than selected on its exporter description alone. A UK trading address, brochure or low price is not proof of lawful supply.
Related product
 | TAZAROTENE GEL 0.05 TAZRET 0.05/ GEL(TOPICAL) contains Tazarotene which belongs to the group of medicines called Retinoids. View product → |
Frequently asked questions
How do I check whether Tazret Gel 0.05 can be supplied lawfully in England?
Check the MHRA medicines database for a UK marketing authorisation and confirm that the proposed supplier can lawfully supply the product in Great Britain. A brand listing or overseas pack does not prove UK authorisation.
Should I use a wholesaler, specials supplier or importer?
Use a wholesaler when an authorised UK product is available, a specials supplier when a lawful unlicensed special is clinically justified and properly prescribed, and an importer when the supply route has the required UK licences and import controls.
What should a procurement specification for tazarotene gel include?
State the active ingredient, 0.05% strength, gel dosage form, brand or generic requirement, tube size, market and pack language, minimum remaining shelf life, storage conditions, batch documentation and delivery destination.
What should a Tazret distributor quote show?
Request unit price, quantity breaks, freight, insurance, customs duty, VAT treatment, handling fees, licensing or testing charges, delivery terms, lead time, shelf life and the documents supplied with each batch.
